Literature DB >> 21831510

Smoke, alcohol consumption and illicit drug use in an Italian population of pregnant women.

Marco De Santis1, Carmen De Luca, Ilenia Mappa, Tomasella Quattrocchi, Licameli Angelo, Elena Cesari.   

Abstract

OBJECTIVE: High-risk behaviours are associated with an increased risk of adverse pregnancy outcomes. Exposure to drugs, infection or radiation is a cause of concern for pregnant women, who contact Teratology Information Services (TIS) to have a counseling but with an accurate medical history is possible to detect additional behavioural risk factors that can significantly interfere with pregnancy outcome. The aim of this study is to describe risk behaviours in a population of Italian women calling our TIS and to identify related maternal factors. STUDY
DESIGN: Between December 2008 and January 2010 we collected data from 503 pregnant women calling our TIS (Telefono Rosso, Rome). We investigated about smoke, alcohol and abuse substances addiction and we also collected demographic data.
RESULTS: Of the 503 women consenting to participate 34% were found to have an additional risk marker during the current pregnancy. Within this group were 22.7% (n=119) who reported smoking, the 17.7% (n=89) admitted to drink and 2 women (0.4%) used illicit drugs. In 13.7% of cases (n=69) reason for calling represented an exposure to teratogenic agents. Unmarried status and previous induced abortion represent a risk factor for all high-risk behaviours. Lower education (p<0.001) and use of neurological drugs (p<0.001) are related with cigarette consumption. A lower parity was a risk factor for alcohol assumption (p=0.04). Women with high-risk behaviours tend to be exposed to more than a risk factor.
CONCLUSIONS: Teratogen Information Services are an important system to identify women with pregnancy risk markers. These services should have the ability to provide risk reduction information to women who smoke cigarettes or with alcohol or drug use. In addition to the phone based information these women may benefit from referral back to their physician for assessment and management of substance use/abuse during pregnancy. Substance abuse risks are often underestimated by pregnant women. Single mothers or women with an history of terminations of pregnancy represents an high-risk population. Physicians should inform their patients about possible risks related to high-risk behaviours during preconception counseling or during the first obstetric visit.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21831510     DOI: 10.1016/j.ejogrb.2011.07.042

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

Review 1.  Cannabis, the pregnant woman and her child: weeding out the myths.

Authors:  S C Jaques; A Kingsbury; P Henshcke; C Chomchai; S Clews; J Falconer; M E Abdel-Latif; J M Feller; J L Oei
Journal:  J Perinatol       Date:  2014-01-23       Impact factor: 2.521

2.  Maternal risk factors for fetal alcohol spectrum disorders in a province in Italy.

Authors:  Mauro Ceccanti; Daniela Fiorentino; Giovanna Coriale; Wendy O Kalberg; David Buckley; H Eugene Hoyme; J Phillip Gossage; Luther K Robinson; Melanie Manning; Marina Romeo; Julie M Hasken; Barbara Tabachnick; Jason Blankenship; Philip A May
Journal:  Drug Alcohol Depend       Date:  2014-10-25       Impact factor: 4.492

Review 3.  The many faces of tobacco use among women.

Authors:  Alicja Sieminska; Ewa Jassem
Journal:  Med Sci Monit       Date:  2014-01-30

4.  Substance Abuse and its Associated Factors among Pregnant Women: A Cross-Sectional Study in the Southeast of Iran.

Authors:  Seyed Mehdi Tabatabaei; Fatemeh Behmanesh-Pour; Alireza Salimi-Khorashad; Maryam Zaboli; Zahra Sargazi-Moakhar; Sedigheh Shaare-Mollashahi
Journal:  Addict Health       Date:  2018-07

5.  National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis.

Authors:  Alireza Jafari; Abdolhalim Rajabi; Mahdi Gholian-Aval; Nooshin Peyman; Mehrsadat Mahdizadeh; Hadi Tehrani
Journal:  Environ Health Prev Med       Date:  2021-01-08       Impact factor: 3.674

6.  Retrospective analysis of the diagnostic yield of newborn drug testing.

Authors:  Kelly E Wood; Lori L Sinclair; Carolyn D Rysgaard; Frederick G Strathmann; Gwendolyn A McMillin; Matthew D Krasowski
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-29       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.